- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Defensive Stocks
U.S. Pharmaceuticals & Biotech Defensive Stocks
Results
15
0 new
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
15 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
KYKO.F | US$16.75 | 0% | 3.7% | US$1.3t | US$21.41 | PE15.4x | E6.1% | 2.3% | ||
CHSY.F | US$0.93 | 0% | -38.7% | US$15.4b | US$1.57 | PE6x | E5.9% | 6.7% | ||
KYKO.Y | US$16.45 | -3.4% | 1.2% | US$1.3t | US$21.03 | PE15.4x | E6.1% | 2.3% | ||
IPSE.Y | US$28.04 | 0.1% | -1.0% | US$9.1b | US$32.65 | PE13.6x | E7.0% | 1.1% | ||
IPSE.F | US$125.37 | 0% | n/a | US$9.1b | US$145.97 | PE13.6x | E7.0% | 1.1% | ||
NPNK.F | US$41.82 | 0% | n/a | US$376.2b | US$62.78 | PE16.1x | E6.8% | 2.1% | ||
TRSB.F | US$0.72 | 0% | n/a | US$13.0b | US$1.04 | PE7.3x | E14.6% | 4.4% | ||
KSPH.F | US$25.00 | 0% | n/a | US$156.5b | US$27.02 | PE14.6x | E-5.3% | 2.5% | ||
OPHL.Y | US$3.74 | -2.3% | -40.0% | US$820.8b | US$4.53 | PE8.6x | E-5.8% | 4.6% | ||
OPHL.F | US$11.35 | -5.7% | -40.5% | US$820.8b | US$13.75 | PE8.6x | E-5.8% | 4.6% | ||
SGIO.Y | US$6.75 | 1.0% | -13.5% | US$1.8t | US$8.00 | PE11.5x | E-0.3% | 2.8% | ||
SGIO.F | US$12.41 | -9.5% | -20.0% | US$1.8t | US$14.70 | PE11.5x | E-0.3% | 2.8% | ||
APNH.Y | US$9.65 | 2.0% | 4.1% | US$75.5b | US$12.87 | PE17.2x | E22.4% | 2.1% | ||
SMHG.F | US$0.69 | 0% | n/a | US$13.9b | US$1.11 | PE17.9x | E24.4% | 3.2% | ||
SHNX.Y | US$18.19 | 0% | n/a | US$15.7b | n/a | PE10.6x | n/a | 2.7% |
Page 1 of 1